IP Library Granted Patent US 9,315,495
Granted Patent B2
US 9,315,495 · App. 14/409,407 · Granted Apr 19, 2016

Antibacterial agents: aryl myxopyronin derivatives

Inventors: Richard H. Ebright (New Brunswick, NJ); Yon W. Ebright (New Brunswick, NJ); Juan Shen (New Brunswick, NJ); James Bacci (Monmouth Junction, NJ); Anne-Cecile Hiebel (Monmouth Junction, NJ); William Solvibile (Monmouth Junction, NJ); Christopher Self (Monmouth Junction, NJ); Gary Olson (Monmouth Junction, NJ)
Assignees: Rutgers, The State University of New Jersey; Provid Pharmaceuticals Inc.
C07D417/06C07D309/36C07D309/38C07D405/06C07D405/12C07D407/06C07D407/12C07D409/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,495
App. No.
14/409,407
Granted
Apr 19, 2016
Kind
B2
Abstract

The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

Claims (52)

1. A compound of formula Ia, Ib or Ic:

or a salt thereof, wherein:

W is sulfur, oxygen, or nitrogen;

X, Y, and Z are individually carbon, sulfur, oxygen, or nitrogen, wherein at least two of X, Y, and Z are carbon;

one of R 1 and R 2 is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 1 -C 10 alkoxy, aryloxy, heteroaryloxy, or NR a N b , wherein any C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy, is optionally substituted by at least one of halogen, hydroxy, C 1 -C 5 alkoxy, tetrahydrofuranyl, or furanyl, and wherein any aryloxy or heteroaryloxy is optionally substituted by at least one of halogen, hydroxy, C 1 -C 5 alkyl, or C 1 -C 5 alkoxy, wherein any C 1 -C 5 alkyl and C 1 -C 5 alkoxy is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy; or

one of R 1 and R 2 is a 5-6-membered saturated, partially unsaturated, or aromatic heterocycle that is optionally substituted by at least one of halogen, hydroxy, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy; and the other of R 1 and R 2 is absent or is one of H, halogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy, wherein any C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy;

R 3 is absent, or is one of H, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

R 4 is absent, or is one of H, halogen, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

V′, W′, X′, Y′, and Z′ are individually carbon or nitrogen; wherein at least three of V′, W′, X′, Y′, and Z′ are carbon;

one of R 1′ and R 2′ is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 1 -C 10 alkoxy, aryloxy, heteroaryloxy, or NR a R b , wherein any C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy, is optionally substituted by at least one of halogen, hydroxy, C 1 -C 5 alkoxy, tetrahydrofuranyl, or furanyl, and wherein any aryloxy or heteroaryloxy is optionally substituted by at least one of halogen, hydroxy, C 1 -C 5 alkyl, or C 1 -C 5 alkoxy, wherein any C 1 -C 5 alkyl and C 1 -C 5 alkoxy is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy; or

one of R 1′ and R 2′ is a 5-6-membered saturated, partially unsaturated, or aromatic heterocycle that is optionally substituted by at least one of halogen, hydroxy, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy; and the other of R 1′ and R 2′ is absent or is one of H, halogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy, wherein any C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy;

R 3′ , R 4′ , and R 5′ are each independently absent, H, halogen, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

W″ is sulfur, oxygen, or nitrogen;

U″, V″, X″, Y″, and Z″ are individually carbon, sulfur, oxygen, or nitrogen, wherein at least three of U″, V″, X″, Y″, and Z″ are carbon;

one of R 1″ and R 2″ is C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 1 -C 10 alkoxy, aryloxy, heteroaryloxy, or NR a R b , wherein any C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy, is optionally substituted by at least one of halogen, hydroxy, C 1 -C 5 alkoxy, tetrahydrofuranyl, or furanyl, and wherein any aryloxy or heteroaryloxy is optionally substituted by at least one of halogen, hydroxy, C 1 -C 5 alkyl, or C 1 -C 5 alkoxy, wherein any C 1 -C 5 alkyl and C 1 -C 5 alkoxy is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy; or

one of R 1″ and R 2″ is a 5-6-membered saturated, partially unsaturated, or aromatic heterocycle that is optionally substituted by at least one of halogen, hydroxy, alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy; and the other of R 1″ and R 2″ is absent or is one of H, halogen, C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy, wherein any C 1 -C 10 alkyl, C 2 -C 10 alkenyl, or C 1 -C 10 alkoxy is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy;

R 3′ is absent or is one of H, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

R 4″ , R 5″ , and R 6″ are each independently absent, H, halogen, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

R 5 and R 6 are individually H or methyl;

G is one of —CH═CH—NHC(O)—R 7 , —CH═CH—NHC(S)—R 7 , —CH 2 CH 2 NHC(O)—R 7 , —CH 2 CH 2 NHC(S)—R 7 , —CH 2 NHNHC(O)—R 7 , or —CH 2 NHNHC(S)—R 7 ;

R 7 is one of C 1 -C 6 alkyl, —O(C 1 -C 6 alkyl), —S(C 1 -C 6 alkyl), or —N(R 8 ) 2 ;

each R 8 is independently one of hydrogen or —C 1 -C 6 alkyl;

R 9 is C 1 -C 10 alkyl or C 2 -C 10 alkenyl, wherein any C 1 -C 10 alkyl or C 2 -C 10 alkenyl is optionally substituted by at least one of halogen, hydroxy, alkoxy, or NR a R b ;

each R a is C 1 -C 10 alkyl that is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy; and

each R b is H or C 1 -C 10 alkyl that is optionally substituted by at least one of halogen, hydroxy, or C 1 -C 5 alkoxy.

2. The compound of formula Ia′, Ib′ or Ic′:

or a salt thereof, wherein:

W is sulfur, oxygen, or nitrogen;

X, Y, and Z are individually carbon, sulfur, oxygen, or nitrogen, wherein at least two of X, Y, and Z are carbon;

one of R 1 and R 2 is C 1 -C 8 alkyl or C 1 -C 8 alkoxy optionally substituted by at least one of halogen, hydroxy, alkoxy, or furanyl; and the other of R 1 and R 2 is absent or is one of H, halogen, or C 1 -C 8 alkyl or C 1 -C 8 alkoxy optionally substituted by at least one of halogen, hydroxy, or alkoxy;

R 3 is absent, or is one of H, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

R 4 is absent, or is one of H, halogen, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

V′, W, X′, Y′, and Z′ are individually carbon or nitrogen; wherein at least four of V′, W′, X′, Y′, and Z′ are carbon;

one of R 1′ and R 2′ is C 1 -C 5 alkyl or C 1 -C 8 alkoxy optionally substituted by at least one of halogen, hydroxy, or alkoxy, or furanyl; and the other of R 1′ and R 2′ is absent, or is one of H, halogen, or C 1 -C 8 alkyl or C 1 -C 8 alkoxy optionally substituted by at least one of halogen, hydroxy, or alkoxy;

R 3′ , R 4′ , and R 5′ each is absent, or each of R 3′ , R 4′ , and R 5′ is one of is H, halogen, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

W″ is sulfur, oxygen, or nitrogen;

U″, V″, X″, Y″, and Z″ are individually carbon, sulfur, oxygen, or nitrogen, wherein at least three of U″, V″, X″, Y″, and Z″ are carbon;

one of R 1″ and R 2″ is C 1 -C 8 alkyl or C 1 -C 5 alkoxy optionally substituted by at least one of halogen, hydroxy, or alkoxy, or furanyl; and the other of R 1 ″ and R 2 ″ is absent, or is one of H, halogen, or C 1 -C 8 alkyl or C 1 -C 8 alkoxy optionally substituted by at least one of halogen, hydroxy, or alkoxy;

R 3″ is absent or is one of H, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl;

R 4″ , R 5″ , and R 6″ each is absent, or each of R 4″ , R 5″ , and R 6″ is H, halogen, C 1 -C 2 alkyl, or halogen-substituted C 1 -C 2 alkyl; and

R 5 and R 6 are individually H or methyl;

G is one of —CH═CH—NHC(O)—R 7 , —CH═CH—NHC(S)—R 7 , —CH 2 CH 2 NHC(O)—R 7 , —CH 2 CH 2 NHC(S)—R 7 , —CH 2 NHNHC(O)—R 7 , or —CH 2 NHNHC(S)—R 7 , R 7 is one of C 1 -C 6 alkyl, —O(C 1 -C 6 alkyl), —S(C 1 -C 6 alkyl), or —N(R 8 ) 2 ; and

each R 8 is independently one of hydrogen or —C 1 -C 6 alkyl.

3. The compound of claim 1 , which is a compound of formula Ia, or a salt thereof.

4. The compound of claim 1 , which is a compound of formula Ib, or a salt thereof.

5. The compound of claim 1 , which is a compound of formula Ic, or a salt thereof.

6. The compound of claim 1 , or a salt thereof, wherein R 6 is H.

7. The compound of claim 1 , or a salt thereof, wherein R 6 is methyl.

8. A compound selected from

and salts thereof.

9. The compound of claim 1 , or a salt thereof, wherein the salt is a pharmaceutically acceptable salt.

10. A composition comprising the compound of claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2016
From: SOLVIBLE, WILLIAM
To: PROVID PHARMACEUTICALS INC.
Reel/Frame 038323/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2016
From: BACCI (FOR ESTATE OF JAMES BACCI), CHRISTINA
To: PROVID PHARMACEUTICALS, INC.
Reel/Frame 038290/0735 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2016
From: HIEBEL, ANNE-CECILE
To: PROVID PHARMACEUTICALS, INC.
Reel/Frame 038290/0744 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: EBRIGHT, RICHARD H.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 037812/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: OLSON, GARY, DR.; SELF, CHRISTOPHER, DR.
To: PROVID PHARMACEUTICALS INC.
Reel/Frame 037812/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: EBRIGHT, RICHARD H., DR.; EBRIGHT, YON W., DR.; SHEN, JUAN, DR.
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 037812/0408 →
Continuity (2)
Provisional Application 61661670 · Jun 19, 2012
Related Publication 20150197512A1 · Jul 16, 2015